PRS14 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEXICO

B. Briones; G. Zuñiga; F. García-Contreras

doi:10.1016/j.jval.2011.02.775

PRS14 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEXICO

Value in Health ◽

10.1016/j.jval.2011.02.775 ◽

2011 ◽

Vol 14 (3) ◽

pp. A139

Author(s):

B. Briones ◽

G. Zuñiga ◽

F. García-Contreras

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of a single-inhaler triple therapy for patients with advanced chronic obstructive pulmonary disease (COPD) using the FULFIL trial: A UK perspective

Respiratory Medicine X ◽

10.1016/j.yrmex.2019.100008 ◽

2019 ◽

Vol 1 ◽

pp. 100008

Author(s):

Melanie Schroeder ◽

Dhvani Shah ◽

Nancy Risebrough ◽

Alan Martin ◽

Shiyuan Zhang ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Triple Therapy ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis Of A Pharmacist-Led Intervention On Improving Inhaler Adherence In Patients With Chronic Obstructive Pulmonary Disease

Value in Health ◽

10.1016/j.jval.2014.03.788 ◽

2014 ◽

Vol 17 (3) ◽

pp. A136

Author(s):

JF van Boven ◽

E Tommelein ◽

K Boussery ◽

E Mehuys ◽

S Vegter ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease in Spain

Value in Health ◽

10.1016/j.jval.2013.08.287 ◽

2013 ◽

Vol 16 (7) ◽

pp. A372 ◽

Cited By ~ 1

Author(s):

C. Torres ◽

I. Betoret ◽

E. Sabater ◽

M. Figueras ◽

M.A. Casado

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Glycopyrronium Bromide ◽

Effectiveness Analysis

Download Full-text

Clinical Trial-Based Cost-Effectiveness Analysis of Indacaterol (ONBREZ® 150 MCG) Versus Tiotropium (SPIRIVA®) in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) IN TURKEY

Value in Health ◽

10.1016/j.jval.2014.08.2011 ◽

2014 ◽

Vol 17 (7) ◽

pp. A588

Author(s):

M. Saylan ◽

V. Beykoz ◽

A. Keskinaslan

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Clinical Trial ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

Evaluating the cost-effectiveness of combination inhalers for the management of chronic obstructive pulmonary disease

British Journal of Healthcare Management ◽

10.12968/bjhc.2020.0126 ◽

2020 ◽

Vol 26 (9) ◽

pp. 231-233

Author(s):

Matthew Taylor ◽

Michelle Green

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Valuable Insight ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis ◽

The Cost ◽

Insight Into

Matthew Taylor and Michelle Green provide a valuable insight into methods of vital cost-effectiveness analysis of combination inhalers for the management of chronic obstructive pulmonary disease.

Download Full-text

Comparative Cost-effectiveness Analysis of Theophylline and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease

CHEST Journal ◽

10.1378/chest.103.3.678 ◽

1993 ◽

Vol 103 (3) ◽

pp. 678-684 ◽

Cited By ~ 16

Author(s):

Amal Jubran ◽

Nicholas Gross ◽

Joe Ramsdell ◽

Raffi Simonian ◽

Karl Schuttenhelm ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Ipratropium Bromide ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Comparative Cost ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Indacaterol/Glycopirronium (QVA149) as a Maintenance Bronchodilator Treatment in Adult Patients With Chronic Obstructive Pulmonary Disease in Spain

Value in Health ◽

10.1016/j.jval.2014.08.2066 ◽

2014 ◽

Vol 17 (7) ◽

pp. A598

Author(s):

M. Granell ◽

M. Giovanna ◽

S. Paz ◽

I. Betoret

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Adult Patients ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis ◽

Bronchodilator Treatment

Download Full-text

Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis

Respiratory Research ◽

10.1186/1465-9921-15-66 ◽

2014 ◽

Vol 15 (1) ◽

pp. 66 ◽

Cited By ~ 33

Author(s):

Job FM van Boven ◽

Eline Tommelein ◽

Koen Boussery ◽

Els Mehuys ◽

Stefan Vegter ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text

PRP7: COST-EFFECTIVENESS ANALYSIS OF SEQUENTIAL TREATMENT WITH ALMITRINE BISMESYLATE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Value in Health ◽

10.1016/s1098-3015(11)71640-0 ◽

2001 ◽

Vol 4 (6) ◽

pp. 463

Author(s):

D Gorecka ◽

R Jaworski ◽

M Czech ◽

R Pachocki ◽

S Corcaud

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Sequential Treatment ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Almitrine Bismesylate ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Umeclidinium Bromide/Vilanterol 62.5/25 MCG Versus Tiotropium/Olodaterol 5/5 MCG in Symptomatic Patients with Chronic Obstructive Pulmonary Disease in Spain

Value in Health ◽

10.1016/j.jval.2018.04.1583 ◽

2018 ◽

Vol 21 ◽

pp. S233

Author(s):

M Driessen ◽

J Whalen ◽

B Seewoodharry Buguth ◽

LA Vallejo-Aparicio ◽

I Naya ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Cost Effectiveness Analysis ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Effectiveness Analysis

Download Full-text